Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Arm Weakness as a Consequence of Stroke clinical trials
2 of 3 indexed Arm Weakness as a Consequence of Stroke trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Arm Weakness as a Consequence of Stroke: 3 US clinical trials tracked, 2 recruiting.
Arm Weakness as a Consequence of Stroke is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Duke University, running 2 of these trials.
Enrollment posture brief
Registry condition arm-weakness-as-a-consequence-of-stroke
OPEN 2 | RECR 67% | LATE 0 | EARLY 0 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Arm Weakness as a Consequence of Stroke lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Arm Weakness as a Consequence of Stroke on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Arm Weakness as a Consequence of Stroke is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients.
Duke University
NCT06765642
Low Intensity Focused Ultrasound Stimulation in Stroke Patients - Parameter Optimization
Duke University
NCT07220005
Effects of a Compliant Arm Support on Post-stroke Upper Extremity Range of Motion
Stanford University
NCT03867838
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Arm Weakness as a Consequence of Stroke records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Arm Weakness as a Consequence of Stroke trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Arm Weakness as a Consequence of Stroke page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Arm Weakness as a Consequence of Stroke trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Duke University sponsors the most Arm Weakness as a Consequence of Stroke trials on record, review their full trial history before evaluating a specific study. See Duke University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Arm Weakness as a Consequence of Stroke condition card totals 3 registered trials; most-linked intervention compliant support; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.